6 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
TEVA Teva Pharmaceutical Industries Limited $23.43 $23.86B N/A
Article Searches
Teva Pharmaceutical's Tourette Syndrome Drug Fails to Meet Endpoints https://www.fool.com/investing/2020/02/19/teva-pharmaceuticals-tourette-syndrome-drug-fails.aspx?source=iedfolrf0000001 Feb 19, 2020 - It's a disappointing setback for a drug that has received previous approvals for similar conditions.
Stocks making the biggest moves in the premarket: ViacomCBS, E-Trade, Zillow, IMAX & more https://www.cnbc.com/2020/02/20/stocks-making-the-biggest-moves-in-the-premarket-viacomcbs-e-trade-zillow-imax-more.html Feb 20, 2020 - The stocks making the biggest moves in premarket trading include ViacomCBS, E-Trade, Zillow, IMAX, and more.
Teva: The Road To Perdition Has Turned Into A Path Towards Redemption https://seekingalpha.com/article/4325166-teva-road-to-perdition-turned-path-towards-redemption?source=feed_tag_israel Feb 19, 2020 - Stock price has bounced significantly, debt load has declined substantially, and bond yields have fallen meaningfully.More than anything, the recent earnings report has proven that the company remains
3 Reasons Why Teva Pharmaceutical Is Still A Good Buy https://seekingalpha.com/article/4325291-3-reasons-why-teva-pharmaceutical-is-still-good-buy?source=feed_tag_israel Feb 19, 2020 - Teva exceeded market expectations in the fourth quarter.Prospects continue to improve, driven by strong generic pipeline and two drugs.Fair value on Teva stock modelled.
3 Best Drugmakers That Are Immune to Coronavirus Fright http://www.zacks.com/stock/news/777026/3-best-drugmakers-that-are-immune-to-coronavirus-fright?cid=CS-ZC-FT-analyst_blog|investment_ideas-777026 Feb 21, 2020 - The global reliance on China for APIs and drug manufacturing might hit supply chains and production amid the Coronavirus outbreak. Thus, companies independent of China's input are up for grabs now.
Emergent (EBS) Earnings Miss in Q4, Revenues Beat Estimates http://www.zacks.com/stock/news/777571/emergent-ebs-earnings-miss-in-q4-revenues-beat-estimates?cid=CS-ZC-FT-analyst_blog|earnings_article-777571 Feb 21, 2020 - Emergent's (EBS) earnings lag estimates in Q4 while revenues surpass the mark.

Pages: 1

Page 1